文献速递生殖医学

评估辅助卵母细胞激活在卵胞浆内单精子注射中的有效性:配对Meta分析与系统证据评价

Evaluating the Effectiveness of Assisted Oocyte Activation in ICSI: Pairwise Meta-Analyses and Systematic Evidence Evaluation.
PubMed 文献 · BJOG · 2025-01-30

该研究系统检索1990年1月至2024年3月文献,纳入45项研究,覆盖56 787个成熟卵母细胞、7 463名临床妊娠女性及7 063名活产女性。配对Meta分析显示,辅助卵母细胞激活可能提高有低受精或不受精史患者的受精率,但未改善胚胎发育或临床结局,且排除低质量研究或仅分析随机对照试验后此效应减弱;其他患者群体获益有限或无显著获益。

要点

  • 辅助卵母细胞激活可能提高有低受精或不受精史患者的受精率。
  • 辅助卵母细胞激活未改善胚胎发育或临床结局。
  • 排除低质量研究或仅分析随机对照试验后,受精率改善效应减弱。

核心结论

  • 辅助卵母细胞激活可能改善有受精问题患者的受精率,但对胚胎发育或活产率无获益。

研究设计与样本

  • 系统评价与配对Meta分析,检索PubMed、Cochrane和Scopus从1990年1月至2024年3月,纳入随机对照试验、准实验研究、队列研究和病例对照研究共45项,覆盖56 787个成熟卵母细胞、7 463名临床妊娠女性和7 063名活产女性。

主要发现

  • 辅助卵母细胞激活可能提高有低受精或不受精史患者的受精率,但未改善胚胎发育或临床结局。
  • 排除低质量研究或仅分析随机对照试验后,该效应减弱。
  • 在其他患者群体中,辅助卵母细胞激活的获益有限或无显著获益。

关键数值与推荐

  • 采用随机效应模型进行Meta分析,使用Joanna Briggs Institute(JBI)检查清单评价研究质量,并采用综合数值框架对证据进行分类。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Artificial oocyte activation (AOA) is used to improve fertilisation rates in intracytoplasmic sperm injection (ICSI) cycles. OBJECTIVES: To assess the effectiveness of AOA on fertilisation, embryo development, and clinical outcomes, including live birth. SEARCH STRATEGY: We searched PubMed, Cochrane, and Scopus from January 1990 to March 2024 using terms related to 'artificial oocyte activation' and 'ICSI.' SELECTION CRITERIA: Study designs included randomised trials (RCTs), quasi-experimental, cohort, and case-control studies that evaluated AOA's effects on ICSI outcomes, provided quantitative data and were published in English. DATA COLLECTION AND ANALYSIS: Reviewers independently performed data extraction using a standardised form. Study quality was appraised using Joanna Briggs Institute (JBI) Checklists. Meta-analyses employed a random-effects model, and evidence was classified using a comprehensive numerical framework. MAIN RESULTS: We included 45 studies covering 56 787 mature oocytes, 7463 women for clinical pregnancies, and 7063 women for live births. AOA showed potential in increasing fertilisation rates in patients with a history of low or absent fertilisation but did not enhance embryo development or clinical outcomes. This effect diminished when excluding low-quality studies or focusing solely on RCTs. In other patient groups, AOA showed limited or nonsignificant benefits. CONCLUSIONS: Applying comprehensive evidence assessment, AOA showed potential in improving fertilisation rates in patients with fertilisation problems but no benefits for embryo development or live birth rates. This underscores the critical importance of rigorous evidence credibility in informing clinical practice in assisted conception.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Fawzy M, Elsuity MA, Magdi Y, et al. Evaluating the Effectiveness of Assisted Oocyte Activation in ICSI: Pairwise Meta-Analyses and Systematic Evidence Evaluation. BJOG. 2025. PMID: 39888192. doi:10.1111/1471-0528.18085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。